🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseAlcohol + MASH + GLP-1 — 6 month update Page 2

Alcohol + MASH + GLP-1 — 6 month update

matt_MKE Wed, Mar 26, 2025 at 11:39 PM 13 replies 1,673 viewsPage 2 of 3
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Mar 27, 2025 at 8:31 AM#6
JennaRN said:
The liver data is among the strongest non-weight findings in the class.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Pushing back on the consensus forming here. Consistency is not the same as correctness, and a board that agrees with itself quickly is usually agreeing with the first person who sounded certain.

9 4josh_phd_bmore, roxy_nash, tony_orlando and 6 others
Reply Quote Save Share Report
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Mar 27, 2025 at 12:00 PM#7

The figures, for anyone assembling their own picture. With resmetirom now available for MASH, combination approaches are being explored, so the standard of care in this area is moving faster than most threads assume.

Happy to go further on any of that.

8 3JessicaH_TX, KevinCompounds, TirzTom and 5 others
Reply Quote Save Share Report
TrialNerd_Beth
Senior Member
2,345
11,234
Jan 2024
Bethesda, MD
Mar 27, 2025 at 3:29 PM#8
TirzTom said:
Pushing back on the consensus forming here.

Coming at TirzTom’s question from a different direction. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

7 2TomTeleRx, DoseLogDan, SleepFixSam and 4 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Mar 27, 2025 at 6:59 PM#9

A narrower follow-up, since the general answer is now clear:

Whether normalised enzymes tell you anything about fibrosis, and what the right follow-up measurement is?

6 1MikeKY_noInsulin, Dr.RaviCardio, jennifer_SEA and 3 others
Reply Quote Save Share Report
matt_MKE
Member
312
1,345
Sep 2024
Milwaukee, WI
Mar 28, 2025 at 11:45 AM#10

OP back with an update, since a thread like this is useless without one.

Closing this out. What actually changed my mind was the point about waiting for a trend instead of reading a single measurement, which is embarrassing in hindsight and worth saying anyway.

40 13DanielChem_CHI, marco_milano, pam_columbus and 37 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register